Cash flow UnitedHealth Group Inc.

Equities

UNH

US91324P1021

Managed Healthcare

Real-time Estimate Cboe BZX Other stock markets 11:38:11 2026-04-15 EDT			5-day change	1st Jan Change
312.76 ^USD	-0.45%		+2.51%	-4.98%

06:08am	Baird Adjusts Price Target on UnitedHealth to $278 From $291, Maintains Underperform Rating	MT
04-13	States, insurers await needed details to implement new US Medicaid work rules	RE

ffd13b6182b35c4fc2a4b13e0.-P9di2ohv7TiOBgLUZK95Q6rB-VLZMb4j4NSPyt5jXA.nsY64yIW7PaWTy0mHdeIpmqZa7ICD5eg58UNSFwK4SKznRnmP1bG-pRzcw

Published financial data: UNITEDHEALTH GROUP INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Premiums and Annuity Revenues	226B	257B	291B	309B	352B
Total Interest And Dividend Income	2.32B	2.03B	3.81B	4.49B	4.28B
Gain (Loss) on Sale of Investments, Total (Rev)	-	-	276M	710M	-360M
Non-Insurance Activities Revenues	34.44B	37.42B	42.58B	50.23B	53.38B
Other Revenues, Total	24.6B	27.55B	34.12B	36.04B	38.04B
Total Revenues	288B	324B	372B	400B	448B
Policy Benefits	187B	211B	242B	264B	314B
Depreciation & Amortization - (IS) - (Collected)	3.1B	3.4B	3.97B	4.1B	4.36B
Selling General & Admin Expenses, Total	42.58B	47.78B	54.63B	53.01B	59.59B
Non-Insurance Activities Expenses	31.03B	33.7B	38.77B	46.69B	50.66B
Total Operating Expenses	264B	296B	339B	368B	429B
Operating Income	23.97B	28.44B	32.36B	32.29B	18.96B
Interest Expense, Total	-1.66B	-2.09B	-3.25B	-3.91B	-4B
EBT, Excl. Unusual Items	22.31B	26.34B	29.11B	28.38B	14.96B
Gain (Loss) on Sale of Assets	-	-	-	-8.31B	-265M
EBT, Incl. Unusual Items	22.31B	26.34B	29.11B	20.07B	14.7B
Income Tax Expense	4.58B	5.7B	5.97B	4.83B	1.89B
Earnings From Continuing Operations	17.73B	20.64B	23.14B	15.24B	12.81B
Net Income to Company	17.73B	20.64B	23.14B	15.24B	12.81B
Minority Interest	-447M	-519M	-763M	-837M	-751M
Net Income - (IS)	17.28B	20.12B	22.38B	14.4B	12.06B
Net Income to Common Incl Extra Items	17.28B	20.12B	22.38B	14.4B	12.06B
Net Income to Common Excl. Extra Items	17.28B	20.12B	22.38B	14.4B	12.06B
Per Share Items
Net EPS - Basic	18.33	21.47	24.12	15.64	13.28
Basic EPS - Continuing Operations	18.33	21.47	24.12	15.64	13.28
Basic Weighted Average Shares Outstanding	943M	937M	928M	921M	908M
Net EPS - Diluted	18.08	21.18	23.86	15.51	13.23
Diluted EPS - Continuing Operations	18.08	21.18	23.86	15.51	13.23
Diluted Weighted Average Shares Outstanding	956M	950M	938M	929M	911M
Normalized Basic EPS	14.31	17.02	18.78	18.35	9.47
Normalized Diluted EPS	14.12	16.78	18.58	18.19	9.44
Dividend Per Share	5.6	6.4	7.29	8.18	8.73
Payout Ratio	30.55	29.78	30.21	52.29	65.66
American Depositary Receipts Ratio (ADR)	0.01	0.01	0.01	0.01	0.01
Supplemental Items
EBITDA	26.15B	30.84B	35.13B	34.99B	21.62B
EBITA	25.17B	29.74B	33.96B	33.99B	20.66B
EBIT	23.97B	28.44B	32.36B	32.29B	18.96B
EBITDAR	27.35B	32.14B	36.53B	36.39B	23.22B
Total Revenues (As Reported)	288B	324B	372B	400B	448B
Effective Tax Rate - (Ratio)	20.52	21.65	20.5	24.06	12.86
Current Domestic Taxes	3.93B	5.7B	5.13B	3.87B	1.98B
Current Foreign Taxes	516M	680M	1.08B	1.26B	1.66B
Total Current Taxes	4.45B	6.38B	6.21B	5.12B	3.64B
Deferred Domestic Taxes	-	-	-	-	-1.38B
Deferred Foreign Taxes	-	-	-	-	-376M
Total Deferred Taxes	130M	-673M	-245M	-296M	-1.75B
Normalized Net Income	13.5B	15.95B	17.43B	16.9B	8.6B
Supplemental Operating Expense Items
Net Rental Expense, Total	1.2B	1.3B	1.4B	1.4B	1.6B
Imputed Operating Lease Interest Expense	340M	401M	581M	606M	641M
Imputed Operating Lease Depreciation	860M	899M	819M	794M	959M
Stock-Based Comp., SG&A Exp. (Total)	-	925M	1.06B	1.02B	971M
Stock-Based Comp., Other (Total)	800M	-	-	-	-
Total Stock-Based Compensation	800M	925M	1.06B	1.02B	971M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Total Other Investments	43.85B	46.67B	49.91B	54.06B	55.81B
Total investments	43.85B	46.67B	49.91B	54.06B	55.81B
Cash And Equivalents	21.38B	23.36B	25.43B	25.31B	24.36B
Other Receivables - (Insurance Template)	28.08B	30.45B	38.97B	48.45B	52.72B
Separate Account Assets	4.45B	4.09B	3.76B	-	-
Gross Property Plant And Equipment	9.25B	10.42B	10.67B	8.54B	8.46B
Accumulated Depreciation	-3.86B	-4.5B	-4.21B	-3.64B	-3.72B
Net Property Plant And Equipment	5.39B	5.92B	6.46B	4.9B	4.74B
Goodwill	75.8B	93.35B	104B	107B	110B
Other Intangibles, Total	13.62B	18.61B	20.19B	28.93B	26.49B
Other Current Assets, Total	5.32B	6.62B	6.08B	8.21B	9.75B
Other Long-Term Assets, Total	14.33B	16.63B	19.2B	21.69B	25.21B
Total Assets	212B	246B	274B	298B	310B
Liabilities
Accounts Payable, Total	24.64B	27.72B	31.96B	34.34B	38.03B
Insurance And Annuity Liabilities	-	-	-	-	-
Unpaid Claims	24.48B	29.06B	32.4B	34.22B	39.34B
Unearned Premiums	2.57B	3.08B	3.36B	3.32B	3.41B
Current Portion of Long-Term Debt	3.62B	2.31B	3.19B	3.24B	3.82B
Current Portion of Leases	870M	997M	1.04B	1.01B	1.05B
Short-Term Borrowings	-	800M	1.09B	1.3B	2.25B
Long-Term Debt	42.38B	54.51B	58.26B	72.36B	72.32B
Long-Term Leases	3.4B	3.83B	3.86B	3.88B	3.56B
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	22.1B	25.28B	26.03B	26.33B	26.99B
Deferred Tax Liability Non-Current	3.26B	2.77B	3.02B	3.62B	2.42B
Other Non Current Liabilities	8.38B	9.01B	10.6B	12.06B	14.68B
Total Liabilities	136B	159B	175B	196B	208B
Common Stock, Total	10M	9M	9M	9M	9M
Additional Paid In Capital	-	-	-	-	559M
Retained Earnings	77.13B	86.16B	95.77B	96.04B	95.6B
Comprehensive Income and Other	-5.38B	-8.39B	-7.03B	-3.39B	-2.06B
Total Common Equity	71.76B	77.77B	88.76B	92.66B	94.11B
Minority Interest	4.72B	8.58B	10.16B	9.93B	7.59B
Total Equity	76.48B	86.35B	98.92B	103B	102B
Total Liabilities And Equity	212B	246B	274B	298B	310B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	941M	933M	922M	915M	908M
ECS Total Common Shares Outstanding	941M	934M	924M	915M	906M
Book Value / Share	76.26	83.27	96.06	101.27	103.87
Tangible Book Value	-17.66B	-34.19B	-35.16B	-43B	-42.88B
Tangible Book Value Per Share	-18.76	-36.6	-38.06	-47	-47.33
Total Debt	50.28B	62.45B	67.44B	81.79B	83B
Net Debt	28.9B	39.09B	42.01B	56.48B	58.64B
Debt Equivalent Oper. Leases	9.6B	10.4B	11.2B	11.2B	12.8B
Minority Interest, Total (Incl. Fin. Div)	4.72B	8.58B	10.16B	9.93B	7.59B
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	502M	697M	712M	364M	387M
Buildings, Total	4.88B	5.52B	5.57B	4.22B	4.09B
Machinery, Total	3.86B	4.21B	4.38B	3.96B	3.99B
Full Time Employees	350K	400K	440K	400K	390K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	17.28B	20.12B	22.38B	14.4B	12.06B
Depreciation, Depletion & Amortization	980M	1.1B	1.17B	999M	961M
Amortization of Goodwill and Intangible Assets - (CF)	1.2B	1.3B	1.6B	1.7B	1.7B
Total Depreciation, Depletion & Amortization	2.18B	2.4B	2.77B	2.7B	2.66B
Amortization of Deferred Charges, Total	923M	1B	1.2B	1.4B	1.7B
(Gain) Loss On Sale of Asset - (CF)	-	-	-	4.98B	-645M
Stock-Based Compensation (CF)	800M	925M	1.06B	1.02B	971M
Change in Accounts Receivable	-1B	-2.52B	-3.11B	-1.44B	-764M
Change in Accounts Payable	1.16B	1.96B	3.52B	2.46B	1.66B
Change in Unearned Revenues	-310M	126M	203M	-197M	163M
Change in insurance Reserves / Liabilities	2.7B	4.05B	3.48B	2.5B	5.82B
Change in Other Net Operating Assets (Collected)	-1.03B	-1.37B	-2.44B	-4.14B	-4.61B
Other Operating Activities	-367M	-485M	13M	513M	672M
Cash from Operations	22.34B	26.21B	29.07B	24.2B	19.7B
Capital Expenditure	-2.45B	-2.8B	-3.39B	-3.5B	-3.62B
Sale of Property, Plant, and Equipment	-	3.41B	685M	2.04B	561M
Cash Acquisitions	-4.82B	-21.46B	-10.14B	-13.41B	-4.51B
Investment in Marketable and Equity Securities, Total	-1.84B	-6.84B	-1.78B	525M	361M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-4.52B	-1.14B
Other Investing Activities, Total	-1.25B	-793M	-960M	-1.67B	-341M
Cash from Investing	-10.37B	-28.48B	-15.57B	-20.53B	-8.68B
Short Term Debt Issued, Total	-	732M	11M	-	807M
Long-Term Debt Issued, Total	6.93B	14.82B	6.39B	17.81B	2.97B
Total Debt Issued	6.93B	15.55B	6.4B	17.81B	3.78B
Short Term Debt Repaid, Total	-1.3B	-	-	-151M	-
Long-Term Debt Repaid, Total	-3.15B	-3.02B	-2.12B	-3B	-3.05B
Total Debt Repaid	-4.45B	-3.02B	-2.12B	-3.15B	-3.05B
Issuance of Common Stock	1.36B	1.25B	1.35B	1.85B	827M
Repurchase of Common Stock	-5B	-7B	-8B	-9B	-5.54B
Common Dividends Paid	-5.28B	-5.99B	-6.76B	-7.53B	-7.92B
Common & Preferred Stock Dividends Paid	-5.28B	-5.99B	-6.76B	-7.53B	-7.92B
Other Financing Activities, Total	-1.01B	3.43B	-2.4B	-3.48B	264M
Cash from Financing	-7.46B	4.23B	-11.53B	-3.51B	-11.64B
Foreign Exchange Rate Adjustments	-62M	34M	97M	-61M	40M
Miscellaneous Cash Flow Adjustments	-	-	-	-219M	-355M
Net Change in Cash	4.45B	1.99B	2.06B	-115M	-947M
Supplemental Items
Cash Interest Paid	1.65B	1.94B	3.04B	3.59B	4.03B
Cash Income Tax Paid (Refund)	3.97B	5.22B	6.08B	4.62B	3.71B
Net Debt Issued / Repaid	2.48B	12.54B	4.28B	14.66B	726M
Levered Free Cash Flow	18.38B	22.76B	19.82B	11.57B	13.86B
Unlevered Free Cash Flow	19.42B	24.07B	21.85B	14.02B	16.36B
Change In Net Working Capital	-2.99B	-4.78B	23M	7.78B	-2.8B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.32	7.76	7.79	7.06	3.9
Return on Total Capital	12.44	13.1	13.03	11.67	6.51
Return On Equity %	24.12	25.35	24.98	15.13	12.54
Return on Common Equity	25.19	26.91	26.88	15.88	12.91
Margin Analysis
Gross Profit Margin %	24.22	24.56	24.48	22.33	18.53
SG&A Margin	14.8	14.74	14.7	13.24	13.31
EBITDA Margin %	9.09	9.51	9.45	8.74	4.83
EBITA Margin %	8.75	9.17	9.14	8.49	4.62
EBIT Margin %	8.33	8.77	8.71	8.07	4.24
Income From Continuing Operations Margin %	6.17	6.37	6.23	3.81	2.86
Net Income Margin %	6.01	6.21	6.02	3.6	2.69
Net Avail. For Common Margin %	6.01	6.21	6.02	3.6	2.69
Normalized Net Income Margin	4.69	4.92	4.69	4.22	1.92
Levered Free Cash Flow Margin	6.39	7.02	5.33	2.89	3.1
Unlevered Free Cash Flow Margin	6.75	7.43	5.88	3.5	3.66
Asset Turnover
Asset Turnover	1.4	1.42	1.43	1.4	1.47
Fixed Assets Turnover	52.9	57.3	60.04	70.52	92.89
Receivables Turnover (Average Receivables)	19.42	18.6	17.31	16.66	18.06
Inventory Turnover (Average Inventory)	-	-	89.1	94.21	102.72
Short Term Liquidity
Current Ratio	0.73	0.73	0.75	0.83	0.79
Quick Ratio	0.66	0.65	0.69	0.75	0.7
Operating Cash Flow to Current Liabilities	0.29	0.29	0.29	0.23	0.17
Days Sales Outstanding (Average Receivables)	18.8	19.63	21.08	21.97	20.21
Days Outstanding Inventory (Average Inventory)	-	-	4.1	3.89	3.55
Average Days Payable Outstanding	78.29	79.03	78.96	77.99	73.14
Cash Conversion Cycle (Average Days)	-	-	-53.78	-52.14	-49.38
Long Term Solvency
Total Debt/Equity	65.74	72.33	68.17	79.73	81.62
Total Debt / Total Capital	39.66	41.97	40.54	44.36	44.94
LT Debt/Equity	59.87	67.57	62.8	74.31	74.62
Long-Term Debt / Total Capital	36.12	39.21	37.34	41.35	41.08
Total Liabilities / Total Assets	63.96	64.86	63.86	65.61	67.15
EBIT / Interest Expense	14.44	13.59	9.97	8.27	4.74
EBITDA / Interest Expense	16.48	15.36	11.25	9.32	5.8
(EBITDA - Capex) / Interest Expense	15	14.02	10.21	8.42	4.9
Total Debt / EBITDA	1.84	1.94	1.85	2.25	3.57
Net Debt / EBITDA	1.06	1.22	1.15	1.55	2.52
Total Debt / (EBITDA - Capex)	2.02	2.13	2.03	2.49	4.23
Net Debt / (EBITDA - Capex)	1.16	1.33	1.27	1.72	2.99
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	11.84	12.71	14.64	7.71	11.81
Gross Profit, 1 Yr. Growth %	3.96	14.31	14.24	-1.71	-7.25
EBITDA, 1 Yr. Growth %	6.81	17.81	13.93	-0.41	-38.19
EBITA, 1 Yr. Growth %	7.08	18.14	14.2	0.09	-39.2
EBIT, 1 Yr. Growth %	6.98	18.63	13.8	-0.22	-41.26
Earnings From Cont. Operations, 1 Yr. Growth %	12.45	16.39	12.14	-34.14	-15.98
Net Income, 1 Yr. Growth %	12.22	16.4	11.24	-35.64	-16.31
Normalized Net Income, 1 Yr. Growth %	7.14	18.14	9.32	-3.05	-49.11
Diluted EPS Before Extra, 1 Yr. Growth %	12.79	17.15	12.65	-35	-14.7
Net Property, Plant and Equip., 1 Yr. Growth %	-1.64	9.85	9.02	-24.19	-3.13
Inventory, 1 Yr. Growth %	-	-	-20	35.71	-13.16
Accounts Receivable, 1 Yr. Growth %	10.46	24.37	20.33	5.12	2.92
Total Assets, 1 Yr. Growth %	7.56	15.79	11.4	8.97	3.79
Common Equity, 1 Yr. Growth %	9.57	8.38	14.12	4.4	1.57
Tangible Book Value, 1 Yr. Growth %	-11.04	93.62	2.86	22.29	-0.28
Cash From Operations, 1 Yr. Growth %	0.76	17.29	10.92	-16.73	-18.62
Capital Expenditures, 1 Yr. Growth %	19.65	14.18	20.84	3.34	3.52
Levered Free Cash Flow, 1 Yr. Growth %	-8.21	18.24	-16.59	-44.5	10.13
Unlevered Free Cash Flow, 1 Yr. Growth %	-7.81	18.64	-12.85	-38.75	8.88
Dividend Per Share, 1 Yr. Growth %	15.94	14.29	13.91	12.21	6.72
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	8.98	12.28	13.67	11.12	9.74
Gross Profit, 2 Yr. CAGR %	9.97	9.01	14.28	5.97	-4.52
EBITDA, 2 Yr. CAGR %	9.82	12.2	15.85	6.52	-21.54
EBITA, 2 Yr. CAGR %	10.31	12.47	16.15	6.91	-21.99
EBIT, 2 Yr. CAGR %	10.35	12.66	16.19	6.56	-23.44
Earnings From Cont. Operations, 2 Yr. CAGR %	11.59	14.4	14.25	-14.06	-25.61
Net Income, 2 Yr. CAGR %	11.76	14.29	13.79	-15.39	-26.61
Normalized Net Income, 2 Yr. CAGR %	11.59	12.5	13.65	2.95	-29.76
Diluted EPS Before Extra, 2 Yr. CAGR %	12.32	14.95	14.88	-14.43	-25.54
Net Property, Plant and Equip., 2 Yr. CAGR %	-3.02	3.94	9.43	-9.09	-14.3
Inventory, 2 Yr. CAGR %	-	-	-	4.2	8.56
Accounts Receivable, 2 Yr. CAGR %	9.66	17.21	22.34	12.47	4.01
Total Assets, 2 Yr. CAGR %	10.47	11.6	13.57	10.18	6.35
Common Equity, 2 Yr. CAGR %	11.6	8.97	11.21	9.15	2.97
Tangible Book Value, 2 Yr. CAGR %	-9.09	31.25	41.12	12.16	10.43
Cash From Operations, 2 Yr. CAGR %	10.01	8.71	14.06	-3.9	-17.68
Capital Expenditures, 2 Yr. CAGR %	8.85	16.88	17.46	11.75	3.43
Levered Free Cash Flow, 2 Yr. CAGR %	8.96	6.62	1.46	-30.2	-18.47
Unlevered Free Cash Flow, 2 Yr. CAGR %	8.33	6.9	3.77	-25.23	-15.44
Dividend Per Share, 2 Yr. CAGR %	16.3	15.11	14.1	13.05	9.43
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	8.33	10.21	13.06	11.65	11.35
Gross Profit, 3 Yr. CAGR %	8.96	11.4	10.73	8.68	1.36
EBITDA, 3 Yr. CAGR %	10.91	12.45	12.77	10.16	-11.15
EBITA, 3 Yr. CAGR %	11.33	12.86	13.05	10.53	-11.42
EBIT, 3 Yr. CAGR %	11.39	13.04	13.03	10.44	-12.63
Earnings From Cont. Operations, 3 Yr. CAGR %	12.72	13.17	13.64	-4.92	-14.71
Net Income, 3 Yr. CAGR %	12.98	13.29	13.26	-5.89	-15.69
Normalized Net Income, 3 Yr. CAGR %	12.15	13.73	11.43	7.79	-18.6
Diluted EPS Before Extra, 3 Yr. CAGR %	14.04	13.91	14.18	-4.98	-14.52
Net Property, Plant and Equip., 3 Yr. CAGR %	-2.17	1.09	5.61	-3.17	-7.14
Inventory, 3 Yr. CAGR %	-	-	-	-	-1.94
Accounts Receivable, 3 Yr. CAGR %	7.67	14.36	18.24	16.3	9.19
Total Assets, 3 Yr. CAGR %	11.71	12.21	11.53	12.02	8.01
Common Equity, 3 Yr. CAGR %	11.55	10.52	10.66	8.89	6.56
Tangible Book Value, 3 Yr. CAGR %	-2.82	16.97	21.01	34.54	7.85
Cash From Operations, 3 Yr. CAGR %	12.45	12.38	9.44	2.7	-9.08
Capital Expenditures, 3 Yr. CAGR %	5.96	10.6	18.19	12.55	8.93
Levered Free Cash Flow, 3 Yr. CAGR %	15.9	13.71	-0.35	-15.6	-16.44
Unlevered Free Cash Flow, 3 Yr. CAGR %	15.26	13.31	1.22	-11.6	-13.25
Dividend Per Share, 3 Yr. CAGR %	17.52	15.63	14.71	13.46	10.9
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	9.24	10.01	10.43	10.57	11.72
Gross Profit, 5 Yr. CAGR %	9.93	11.11	11.05	9.19	4.36
EBITDA, 5 Yr. CAGR %	12.5	12.77	12.88	10.04	-2.46
EBITA, 5 Yr. CAGR %	12.75	13.05	13.23	10.44	-2.54
EBIT, 5 Yr. CAGR %	13.14	13.33	13.28	10.4	-3.28
Earnings From Cont. Operations, 5 Yr. CAGR %	20.18	13.78	13.33	1.37	-4.08
Net Income, 5 Yr. CAGR %	19.76	13.77	13.3	0.8	-4.78
Normalized Net Income, 5 Yr. CAGR %	12.9	13.41	12.74	9.29	-7.35
Diluted EPS Before Extra, 5 Yr. CAGR %	20.05	14.59	14.38	1.6	-3.77
Net Property, Plant and Equip., 5 Yr. CAGR %	6.85	5.1	2.32	-3.11	-2.86
Accounts Receivable, 5 Yr. CAGR %	11.76	13.07	13.32	13.6	12.33
Total Assets, 5 Yr. CAGR %	11.56	12.06	12.45	11.4	9.43
Common Equity, 5 Yr. CAGR %	13.4	10.24	11.42	9.97	7.52
Tangible Book Value, 5 Yr. CAGR %	-2.35	14.12	12.82	15.02	16.66
Cash From Operations, 5 Yr. CAGR %	17.93	14.02	13.09	5.56	-2.34
Capital Expenditures, 5 Yr. CAGR %	7.55	6.73	10.42	11.06	12.05
Levered Free Cash Flow, 5 Yr. CAGR %	9.99	11.06	10.91	-5.65	-7.09
Unlevered Free Cash Flow, 5 Yr. CAGR %	9.95	11.11	11.49	-3.27	-4.92
Dividend Per Share, 5 Yr. CAGR %	18.71	17.36	16.14	14.59	12.57